A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2015
At a glance
- Drugs Insulin degludec/insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 29 Jun 2012 Actual end date changed from Jan 2012 to Apr 2012 as reported by ClinicalTrials.gov.
- 17 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2011 Planned end date changed from 1 Feb 2012 to 1 Jan 2012 as reported by ClinicalTrials.gov.